A vaccine against MERS has shown promise in mouse models, potentially aiding the development of a vaccine against COVID-19.
A new study suggests that a human recombinant soluble enzyme blocker, hrsACE2, significantly reduces SARS-CoV-2 viral load in human tissue, suggesting it could have the potential to prevent COVID-19.
Researchers from the University of Pittsburgh (PA, USA) have revealed the results from preclinical research testing their COVID-19 vaccine candidate in mice.
Take a look behind the scenes of a recent Future Virology editorial entitled, ‘An insight into dengue virus proteins as potential drug/vaccine targets’, as we ask author Muhammad Faheem about recent advances in understanding dengue proteins and where the next 5–10 years could take us.
Take a look behind the scenes of a recent Future Virology article, entitled ‘Update on HIV integrase inhibitors for the treatment of HIV’, as we ask the authors about these drugs for HIV treatment and the future of this field.
Take a look behind the scenes of a recent Future Microbiology article, entitled ‘New insights of CRISPR technology in pathogenic fungi’, as we ask author Elvira Román (Complutense University of Madrid, Spain) about the advances CRISPR technology has already brought to this field and the potential it could hold in the future.